Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
When To Use Bond Ladder Retirement Portfolio explains scenarios where a bond ladder can stabilize withdrawals and cushion market swings.
22,278 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Influencer clashes over defamation put a spotlight on money, risk, and what you should scrutinize before backing ever...
When Micron announced a Taiwanese site acquisition, micron stock popped today and sparked a broader discussion about ...
When a company CEO sells thousands of shares, investors take notice. This guide breaks down what National Vision's so...
CoreWeave has surged into the AI infrastructure spotlight, but the ride is not risk-free. This article analyzes the g...
The AI chip rally is shifting from training to real-world inference. This article explains why the next phase chip su...
A sudden 17% intraday surge in Brady Corporation has investors buzzing. This piece breaks down how AI-linked demand f...
Peloton’s leadership change nudges the stock market today into focus. This article breaks down what Sid Thacker’s CFO...
As the next market cycle approaches, traders are weighing XRP against Hyperliquid, weighing price action, liquidity, ...
A respected analyst has earmarked Dutch Bros as the best restaurant stock pick, citing traffic gains, digital momentu...
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Two budding EV stars, Lucid and Rivian, are racing from zero to scale. This deep dive compares their paths, risks, an...